SelectScience InterviewsDrug discovery > Target Discovery
Assay Miniaturization for High Throughput Compound Screening at AstraZeneca
16 Feb 2016
Watch this video to learn how assay miniaturization is enhancing compound screening workflow at AstraZeneca. Helen Plant, a Senior Scientist at the global high throughput screening centre, describes how Corning’s Epic® system is facilitating screening automation and increasing the diversity of compounds screened in assays at AstraZeneca.